These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6641185

  • 1. Effects of bromocriptine for prolactin-secreting adenomas: analysis by CT scan.
    Niwa J, Sato O, Tanabe S.
    Comput Radiol; 1983; 7(4):237-41. PubMed ID: 6641185
    [Abstract] [Full Text] [Related]

  • 2. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
    Bergström M, Muhr C, Lundberg PO, Bergström K, Gee AD, Fasth KJ, Långström B.
    J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
    [Abstract] [Full Text] [Related]

  • 3. Bromocriptine reduction of prolactinoma size.
    Corenblum B, Hanley DA.
    Fertil Steril; 1981 Dec; 36(6):716-9. PubMed ID: 7308514
    [Abstract] [Full Text] [Related]

  • 4. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA, Chang RJ.
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [Abstract] [Full Text] [Related]

  • 5. Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.
    Landolt AM, Minder H, Osterwalder V, Landolt TA.
    Experientia; 1983 Jun 15; 39(6):625-6. PubMed ID: 6852202
    [Abstract] [Full Text] [Related]

  • 6. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
    Crosignani PG, Mattei A, Ferrari C, Giovanelli MA.
    Br J Obstet Gynaecol; 1982 Feb 15; 89(2):169-70. PubMed ID: 7066250
    [Abstract] [Full Text] [Related]

  • 7. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A, Finkel DM, Schatz NJ, Savino PJ, Snyder PJ.
    Ann Intern Med; 1984 Dec 15; 101(6):783-5. PubMed ID: 6497193
    [Abstract] [Full Text] [Related]

  • 8. Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis.
    Mori H, Mori S, Saitoh Y, Arita N, Aono T, Uozumi T, Mogami H, Matsumoto K.
    Cancer; 1985 Jul 15; 56(2):230-8. PubMed ID: 4005795
    [Abstract] [Full Text] [Related]

  • 9. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
    Bonneville JF, Poulignot D, Cattin F, Couturier M, Mollet E, Dietemann JL.
    Radiology; 1982 May 15; 143(2):451-5. PubMed ID: 7071347
    [Abstract] [Full Text] [Related]

  • 10. CT scan of pituitary adenomas.
    Sakoda K, Mukada K, Yonezawa M, Matsumura S, Yoshimoto H, Mori S, Uozumi T.
    Neuroradiology; 1981 Jan 15; 20(5):249-53. PubMed ID: 7465044
    [Abstract] [Full Text] [Related]

  • 11. [Radiological control of prolactin adenomas treated with bromocriptine].
    Metzger J, Gardeur D, Pehuet M, Houlbert D.
    Ann Med Interne (Paris); 1982 Jan 15; 133(1):59-60. PubMed ID: 7065592
    [No Abstract] [Full Text] [Related]

  • 12. Bromocriptine-induced changes in hormone secretion and cell morphology in growth hormone and prolactin producing pituitary adenomas.
    Anniko M, Werner S, Wersäll J.
    Acta Otolaryngol; 1981 Jan 15; 92(3-4):343-55. PubMed ID: 7324902
    [No Abstract] [Full Text] [Related]

  • 13. Changes in computed tomographic findings in microprolactinomas before and after bromocriptine.
    Demura R, Kubo O, Demura H, Shizume K, Kitamura K.
    Acta Endocrinol (Copenh); 1985 Nov 15; 110(3):308-12. PubMed ID: 4072572
    [Abstract] [Full Text] [Related]

  • 14. Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas.
    Jones TH, Figueroa CD, Smith CM, Cullen DR, Bhoola KD.
    J Endocrinol; 1992 Jul 15; 134(1):149-54. PubMed ID: 1500840
    [Abstract] [Full Text] [Related]

  • 15. Rapid decompression of anterior intracranial visual pathways with bromocriptine.
    Grimson BS, Bowman ZL.
    Arch Ophthalmol; 1983 Apr 15; 101(4):604-6. PubMed ID: 6838419
    [Abstract] [Full Text] [Related]

  • 16. Bromocriptine treatment of prolactin secreting macroadenomas: a radiological, ophthalmological and endocrinological study.
    van 't Verlaat JW, Croughs RJ, Hendriks MJ, Bosma NJ, Nortier JW, Thijssen JH.
    Acta Endocrinol (Copenh); 1986 Aug 15; 112(4):487-93. PubMed ID: 3751462
    [Abstract] [Full Text] [Related]

  • 17. Clinical and morphological findings in two cases of bromocriptine-treated prolactinomas.
    Anniko M, Wersäll J.
    Acta Pathol Microbiol Scand A; 1981 Jan 15; 89(1):41-7. PubMed ID: 7223426
    [Abstract] [Full Text] [Related]

  • 18. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
    Verde G, Loli P, Berselli ME, Tagliaferri M, Dallabonzana D, Oppizzi G, Liuzzi A, Chiodini PG, Luccarelli G, Lodrini S.
    J Endocrinol Invest; 1984 Feb 15; 7(1):51-4. PubMed ID: 6715796
    [Abstract] [Full Text] [Related]

  • 19. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM, Scanlon MF, Hall K, Cook DB, Hall R.
    N Engl J Med; 1979 Feb 08; 300(6):291-3. PubMed ID: 759882
    [No Abstract] [Full Text] [Related]

  • 20. Rapid shrinkage of a prolactin-secreting pituitary tumor with bromocriptine: CT documentation.
    Chernow B, Buck DR, Early CB, Ray J, O'Brian JT.
    AJNR Am J Neuroradiol; 1982 Feb 08; 3(4):442-3. PubMed ID: 6810677
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.